SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: saszu who wrote (19501)3/9/1999 9:28:00 PM
From: Little Gorilla  Respond to of 23519
 
>>The clitORIS cream does not have to be 2 years away it could actually be to the fda before the year is out.<<

Wouldn't VVUS have to do Phase I, II, and III studies? I know the main part of Muse Phase III studies (the "at-home" part) took 3 months per patient. And was enrollment staggered? Probably. There were also in-clinic and open-label parts to the Phase III studies.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News